Biochemistry

Asst. Prof. Sutima Luangdilok, M.D., Ph.D.

Position: Lecturer

Expertise:

  • Molecular biology of cancer and Precision Oncology
  • Systemic cancer treatment including molecular targeted
    therapies, chemotherapy, immunotherapy

Google Scholar

Biography

        Assistant Professor Sutima Luangdilok is a board-certified medical oncologist and obtained her PhD from the Institute of Cancer Research: Royal Cancer Hospital, University of London. She graduated with first class honor and complete her medical oncology residency training from Faculty of Medicine Siriraj Hospital, Mahidol University. Currently, she teaches medical students at Faculty of Medicine, Chulalongkorn University and treats cancer patients at King Chulalongkorn Memorial Hospital. Her interest is in precision oncology which integrates understanding of cancer biology to design the most suitable therapies for individual cancer patients.

Education

  • 2010-2014     Medical Oncology, Division of Medical Oncology, Faculty of Medicine Siriraj Hospital 
  • 2007-2010    MD (First Class Honors), Faculty of Medicine Siriraj Hospital, Mahidol University
  • 2003-2007   PhD, the Institute of Cancer Research: Royal Cancer Hospital, University of London, UK
  • 1998-2002    BSc (Medical Science) (First Class Honors), Faculty of Medicine Siriraj Hospital, Mahidol University 

Certifications and licensures

  • 2014    Diplomat, Thai Board of Medical Oncology  
  • 2011    Certificate of Postgraduate Clinical Medical Sciences, Mahidol University, Thailand
  • 2010    Certificate of Medical Licensure, Thailand 

Awards

  • 2015 International Oncology Leading Investigator Training Program, AstraZeneca

  • 2014 International Development and Education Award from Conquer Cancer Foundation of the American Society of Clinical Oncology

  • 2003 PhD scholarship from The Head and Neck Cancer Research Trust, UK

  • 2001 Medical scholars program, Mahidol University

  • 2000 Scholarship award for highest score in Clinical Pathology, Faculty of Medicine Siriraj Hospital
  • 1996 Scholarship award for highest score in Mathematics, Triam Udom Suksa School 

Publications

  1. Akkhasutthikun, P. Kaewsapsak, P. Nimsamer, P. Klomkliew, P. Visedthorn, S. Chanchaem, P. Teerapakpinyo, C. Payungporn, S. Luangdilok, S. Tissue and Plasma-Based Highly Sensitive Blocker Displacement Amplicon Nanopore Sequencing for EGFR Mutations in Lung Cancer. Cancer Res Treat. 2024;56(2):455-63. 
  2. Luangdilok S, Wanchaijiraboon P, Poonchavist Chantranuwatana, Chinachote Teerapakpinyo, Shanop Shuangshoti, Virote Sriuranpong (2019) Cyclin D1 expression as a potential prognostic factor in advanced KRAS-mutant non-small cell lung cancer. Translational Lung Cancer Research 8 (6), 959–966. 
  3. Luangdilok, S., Samarnthai, N., and Korphaisarn, K. (2014). Association between Pathological Complete Response and Outcome Following Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients. J Breast Cancer 17, 376-385.
  4. Teeyapun N, Luangdilok S, Pakvisal N, et al. Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational study. eClinicalMedicine 2022; 52: 101608.
  5. Luangdilok S, Wanchaijiraboon P, Pakvisal N, et al. Immunogenicity after a Third COVID-19 mRNA Booster in Solid Cancer Patients Who Previously Received the Primary Heterologous CoronaVac/ChAdOx1 Vaccine. Vaccines 2022;10(10):1613.

Books

  • สุทิมา เหลืองดิลก ชีววิทยาของมะเร็งปอด ใน วิโรจน์ ศรีอุฬารพงศ์, บรรณาธิการ มะเร็งปอด (LUNG CANCER), e-book ศูนย์หนังสือแห่งจุฬาลงกรณ์มหาวิทยาลัย พ.ศ. 2561 หน้า 1-11 
Scroll to Top